Overview

Prostaglandin Inhibition for Emphysema

Status:
Completed
Trial end date:
2018-03-31
Target enrollment:
Participant gender:
Summary
The Prostaglandin Inhibition for Emphysema (PIE) study will determine if a currently available therapy, ibuprofen 600 mg three times daily, can block PGE production in the lower respiratory tract and if this results in improvement in measures of lung repair function.
Phase:
Phase 2
Details
Lead Sponsor:
University of Nebraska
Collaborators:
National Jewish Health
Temple University
University of Alabama at Birmingham
University of California, Los Angeles
Treatments:
Ibuprofen